ArticleJournal of the American Chemical Society2025
Cleavable Hydrophobic Anchors Optimize Immunomodulatory Effects of Oligonucleotides.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of Positively Charged Backbone Modifications on the Properties of Spherical Nucleic Acids.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Using Well-Defined DNA Nanostructures To Study the Influence of DNA Clustering and Presentation on SNA Cellular Uptake.Nano letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Oligonucleotides (ODNs) are useful in a wide variety of biomedical applications, spanning diagnostics, and therapeutics but are susceptible to nuclease degradation and exhibit poor cellular uptake. Strategies that involve phosphorothioate (PS) backbone modifications and hydrophobic group conjugations have been used to enhance the stability and bioavailability of ODNs. However, improved ODN cellular delivery has not always correlated well with enhancing therapeutic efficacy, particularly in the context of immune modulation. Herein, we propose a theory to explain why this is the case and subsequently present a strategy based upon it to incorporate cleavable linkages between functional ODNs and hydrophobic moieties to simultaneously enhance cellular uptake and improve ODN functionality. Specifically, we synthesized nuclease-cleavable lipid-modified ODNs with phosphodiester (PO)-phosphorothioate (PS) backbone hybrids (POPS). Importantly, these POPS-ODNs exhibit enhanced cellular uptake and functional efficacy compared to their fully PS-modified counterparts. ODN cellular uptake and immunomodulation efficacy were further increased by incorporating POPS-ODNs within a liposomal spherical nucleic acid (SNA) architecture. Our findings highlight the critical balance between enhancing cellular uptake and maintaining therapeutic effectiveness in modified ODN designs, offering insights for optimizing their application in biomedical research and therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.